Similar articles

• Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.

  Bilezikian JP, Dornfeld AM, Gammon DE. Bilezikian JP, et al. Biochem Pharmacol. 1978 May 15;27(10):1445-54. doi: 10.1016/0006-2952(78)90100-4. Biochem Pharmacol. 1978. PMID: 29638 No abstract available.
• Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

  Weiland GA, Minneman KP, Molinoff PB. Weiland GA, et al. Nature. 1979 Sep 13;281(5727):114-7. doi: 10.1038/281114a0. Nature. 1979. PMID: 38405
• Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].

  Vauquelin G, Bottari S, Strosberg AD. Vauquelin G, et al. Arch Int Physiol Biochim. 1979 Oct;87(4):859-60. Arch Int Physiol Biochim. 1979. PMID: 93949 No abstract available.
• Mobility, localization, and heterogeneity of beta-adrenergic receptors.

  Hekman M, Schiltz E, Henis YI, Elson EL, Helmreich EJ. Hekman M, et al. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:47-60. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984. PMID: 6145328 Review. No abstract available.
• Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

  Weiland GA, Molinoff PB. Weiland GA, et al. Life Sci. 1981 Jul 27;29(4):313-30. doi: 10.1016/0024-3205(81)90324-6. Life Sci. 1981. PMID: 6116136 Review. No abstract available.